MPLT
MapLight Therapeutics Inc.

14
52W High
$20.86
Volume
66,256.00
52W Low
$13.33
Price
$13.66
Prev Close
$14.60
MPLT Fundamentals
Open
$14.97
50D MA
$15.86
Beta
0.00
Avg. Volume
855,841.67
EPS (Annual)
-$1.87
P/B
-2.47
Loading...
Loading...
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for MapLight Therapeutics Inc.?
What is the 52-week low for MapLight Therapeutics Inc.?
What is MapLight Therapeutics Inc. stock price today?
What was MapLight Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of MapLight Therapeutics Inc.?
What is the 50-day moving average of MapLight Therapeutics Inc.?

Latest MPLT News

View
No MPLT news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.